Massachusetts Medical Society: Question 5

MENU Massachusetts Medical Society

Question 5

May 19, 2026

 

Question:

 

What is a major safety concern associated with lecanemab and donanemab therapy?

 

 

 

Answers

Answer:

Severe liver failure
 

 

Correct Answer? 

 

Explanation:

 

Answers

Answer:

Amyloid-related imaging abnormalities (ARIA)
 

 

Correct Answer? 

 

Explanation:

 

Answers

Answer:

Permanent hearing loss
 

 

Correct Answer? 

 

Explanation:

 

Answers

Answer:

Renal toxicity
 

 

Correct Answer? 

 

Explanation:

 

 

Format:

Radio buttons (single select)

 

Print
Share on Facebook
Facebook logoLinkedInYouTube logoInstagramThreads

Copyright © 2026. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org